NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV
Post# of 87
(Total Views: 879)
Posted On: 08/14/2020 3:36:12 PM
NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Q1 2021 Financial Results
Canopy Rivers (TSX: RIV) (OTC: CNPOF), today released its unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three months ended June 30, 2020 (“Q1 2021”). “This quarter, we made a strategic investment in Dynaleo, a cannabis gummies manufacturer that we believe is well-positioned to help Canada’s licensed producers and brands catch up to consumer demand for the gummy product format,” Narbé Alexandrian, president and CEO of Canopy Rivers, stated in the news release. “We also continued to work closely with our portfolio companies to help resolve some of the unique macroeconomic challenges that emerged inside and outside of the cannabis sector. While PharmHouse faces some immediate challenges, we continue to believe that it has the potential to become a key component of the Canadian supply chain for low-cost, high-quality cannabis, especially as the value segment of dry flower becomes more prominent.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Canopy Rivers (TSX: RIV) (OTC: CNPOF), today released its unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three months ended June 30, 2020 (“Q1 2021”). “This quarter, we made a strategic investment in Dynaleo, a cannabis gummies manufacturer that we believe is well-positioned to help Canada’s licensed producers and brands catch up to consumer demand for the gummy product format,” Narbé Alexandrian, president and CEO of Canopy Rivers, stated in the news release. “We also continued to work closely with our portfolio companies to help resolve some of the unique macroeconomic challenges that emerged inside and outside of the cannabis sector. While PharmHouse faces some immediate challenges, we continue to believe that it has the potential to become a key component of the Canadian supply chain for low-cost, high-quality cannabis, especially as the value segment of dry flower becomes more prominent.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼